ATM mutations are more difficult to interpret than mutations in other breast cancer susceptibility genes because the risk of cancer may vary by mutation and many of the high penetrance mutations are missense mutations, which are difficult to distinguish from benign polymorphisms. This evidence concerns the gene ATM and breast carcinoma.